Hib-DTP-hepatitis B vaccine (Heber Biotec/Center for Genetic Engineering and Biotechnology)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHib-DTP-hepatitis B vaccine (Heber Biotec/Center for Genetic Engineering and Biotechnology)
Drug Alias NameHeberpenta 4+1Heberpenta-L
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Combination vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis BTetanusDiphtheria +[5] 
Global Approved IndicationsHepatitis BTetanusDiphtheria +[5] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryCuba
Original Approved Date2010/05/01
Country/TerritoryCuba
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCenter For Genetic Engineering And Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsHepatitis BTetanusDiphtheria +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeJ07CA11
Related LinksN/A